Management of Pain in Autosomal Dominant Polycystic Kidney Disease and Anatomy of Renal Innervation

被引:25
|
作者
Tellman, Matthew W. [1 ]
Bahler, Clinton D. [1 ]
Shumate, Ashley M. [1 ]
Bacallao, Robert L. [2 ]
Sundaram, Chandru P. [1 ]
机构
[1] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Nephrol, Indianapolis, IN 46202 USA
来源
JOURNAL OF UROLOGY | 2015年 / 193卷 / 05期
关键词
anatomy; innervation; kidney; pain management; polycystic kidney; autosomal dominant; ANGIOTENSIN-ALDOSTERONE SYSTEM; LEFT-VENTRICULAR HYPERTROPHY; LAPAROSCOPIC NEPHRECTOMY; CYST DECORTICATION; DENERVATION; RADIOFREQUENCY; HYPERTENSION; LIMITATIONS; NEPHROPEXY; DIAGNOSIS;
D O I
10.1016/j.juro.2014.10.124
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Chronic pain is a prominent feature of autosomal dominant polycystic kidney disease that is difficult to treat and manage, often resulting in a decrease in quality of life. Understanding the underlying anatomy of renal innervation and the various etiologies of pain that occur in autosomal dominant polycystic kidney disease can help guide proper treatments to manage pain. Reviewing previously studied treatments for pain in autosomal dominant polycystic kidney disease can help characterize treatment in a stepwise fashion. Materials and Methods: We performed a literature search of the etiology and management of pain in autosomal dominant polycystic kidney disease and the anatomy of renal innervation using PubMed (R) and Embase (R) from January 1985 to April 2014 with limitations to human studies and English language. Results: Pain occurs in the majority of patients with autosomal dominant polycystic kidney disease due to renal, hepatic and mechanical origins. Patients may experience different types of pain which can make it difficult to clinically confirm its etiology. An anatomical and histological evaluation of the complex renal innervation helps in understanding the mechanisms that can lead to renal pain. Understanding the complex nature of renal innervation is essential for surgeons to perform renal denervation. The management of pain in autosomal dominant polycystic kidney disease should be approached in a stepwise fashion. Acute causes of renal pain must first be ruled out due to the high incidence in autosomal dominant polycystic kidney disease. For chronic pain, nonopioid analgesics and conservative interventions can be used first, before opioid analgesics are considered. If pain continues there are surgical interventions such as renal cyst decortication, renal denervation and nephrectomy that can target pain produced by renal or hepatic cysts. Conclusions: Chronic pain in patients with autosomal dominant polycystic kidney disease is often refractory to conservative, medical and other noninvasive treatments. There are effective surgical procedures that can be performed when more conservative treatments fail. Laparoscopic cyst decortication has been well studied and results in the relief of chronic renal pain in the majority of patients. In addition, renal denervation has been used successfully and could be performed concurrently with cyst decortication. Nephrectomy should be reserved for patients with intractable pain and renal failure when other modalities have failed.
引用
收藏
页码:1470 / 1478
页数:9
相关论文
共 50 条
  • [21] Autosomal dominant polycystic kidney disease with contralateral renal agenesis
    Peces, Ramon
    Vega, Cristina
    Aguilar, Ana
    Zometa, Rosa
    Tapia, Claudia
    Peces, Carlos
    Cuesta, Emilio
    NEFROLOGIA, 2012, 32 (06): : 839 - 842
  • [22] Renal Papillary Adenoma in Autosomal Dominant Polycystic Kidney Disease
    Ma, Seong Kwon
    Kim, Sung Sun
    Kim, Soo Wan
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (06) : 439 - 439
  • [23] Renal artery occlusion in autosomal dominant polycystic kidney disease
    Sanchez, Maria
    Enriquez, Ricardo
    Sirvent, Ana E.
    Millan, Isabel
    de la Iglesia, Pedro
    Amoros, Francisco
    RENAL FAILURE, 2014, 36 (07) : 1142 - 1144
  • [24] Autosomal Dominant Polycystic Kidney Disease Associated Renal Neoplasia
    Jones, Derek
    Mirsadraei, Leili
    Argyropoulos, Kimon
    Melamed, Jonathan
    Deng, Fangming
    Park, Kyung
    Ren, Qinghu
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 572 - 572
  • [25] Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease
    Romao, EA
    Moysés, M
    Teixeira, SR
    Muglia, VF
    Vieira, OM
    Dantas, M
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (04) : 533 - 538
  • [26] Renal Replacement Therapies in Autosomal Dominant Polycystic Kidney Disease
    Altintepe, Lutfullah
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2007, 16 : 40 - 45
  • [27] RENAL VOLUME IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Papizh, Svetlana
    Dlin, Vladimir
    Leontieva, Irina
    Tutelman, Konstantin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 73 - 74
  • [28] Renal asymmetry in children with autosomal dominant polycystic kidney disease
    Fick-Brosnahan, G
    Johnson, AM
    Strain, JD
    Gabow, PA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) : 639 - 645
  • [29] Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
    Meijer, Esther
    Rook, Mieneke
    Tent, Hilde
    Navis, Gerjan
    van der Jagt, Eric J.
    de Jong, Paul E.
    Gansevoort, Ron T.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (06): : 1091 - 1098
  • [30] Renal cyst infection in autosomal dominant polycystic kidney disease
    Migali, Gabriela
    Annet, Laurence
    Lonneux, Max
    Devuyst, Olivier
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 404 - 405